HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Wei Li Selected Research

repaglinide (Prandin)

8/2019A Variation in the ABCC8 Gene Is Associated with Type 2 Diabetes Mellitus and Repaglinide Efficacy in Chinese Type 2 Diabetes Mellitus Patients.
1/2018A variant of GRK5 is associated with the therapeutic efficacy of repaglinide in Chinese Han patients with type 2 diabetes mellitus.
11/2016A variation in KCNQ1 gene is associated with repaglinide efficacy on insulin resistance in Chinese Type 2 Diabetes Mellitus Patients.
1/2015PPARD rs2016520 polymorphism affects repaglinide response in Chinese Han patients with type 2 diabetes mellitus.
2/2014Effects of NOS1AP rs12742393 polymorphism on repaglinide response in Chinese patients with type 2 diabetes mellitus.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Wei Li Research Topics

Disease

1480Neoplasms (Cancer)
11/2022 - 01/2002
361Inflammation (Inflammations)
11/2022 - 12/2003
272Neoplasm Metastasis (Metastasis)
07/2022 - 07/2004
238Infections
11/2022 - 10/2003
203Breast Neoplasms (Breast Cancer)
04/2022 - 02/2002
161Carcinogenesis
10/2022 - 01/2002
153Hepatocellular Carcinoma (Hepatoma)
12/2022 - 06/2006
150Stomach Neoplasms (Stomach Cancer)
06/2022 - 11/2004
142Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
10/2022 - 08/2005
111Carcinoma (Carcinomatosis)
01/2022 - 02/2003
110Lung Neoplasms (Lung Cancer)
11/2022 - 06/2006
100Hypoxia (Hypoxemia)
04/2022 - 01/2004
99Fibrosis (Cirrhosis)
09/2022 - 07/2005
85Alzheimer Disease (Alzheimer's Disease)
03/2022 - 01/2007
83Wounds and Injuries (Trauma)
06/2022 - 02/2003
81Prostatic Neoplasms (Prostate Cancer)
01/2022 - 08/2002
80Cardiovascular Diseases (Cardiovascular Disease)
04/2022 - 01/2003
79Pancreatic Neoplasms (Pancreatic Cancer)
04/2022 - 06/2004
76Colorectal Neoplasms (Colorectal Cancer)
07/2022 - 12/2005
74Melanoma (Melanoma, Malignant)
03/2022 - 03/2002
71Body Weight (Weight, Body)
08/2022 - 11/2003
70Insulin Resistance
06/2022 - 07/2009
69Hypertension (High Blood Pressure)
05/2022 - 06/2003
67Necrosis
04/2022 - 04/2003
66Stroke (Strokes)
12/2022 - 07/2004
66Myocardial Infarction
09/2022 - 08/2002
66Thrombosis (Thrombus)
06/2022 - 11/2005
64Atherosclerosis
06/2022 - 01/2003
62Disease Progression
12/2022 - 08/2005
61Leukemia
06/2022 - 10/2004
55Adenocarcinoma
12/2022 - 11/2004
55Pain (Aches)
11/2022 - 07/2002
55Type 2 Diabetes Mellitus (MODY)
05/2022 - 07/2005
52Adenocarcinoma of Lung
06/2022 - 02/2007
51Glioma (Gliomas)
01/2022 - 04/2003
49Heart Failure
04/2022 - 02/2003
49Obesity
02/2022 - 02/2004
47Reperfusion Injury
09/2022 - 04/2008
46COVID-19
06/2022 - 01/2020
46Ischemia
02/2022 - 02/2003
44Cognitive Dysfunction
12/2022 - 01/2012
43Sepsis (Septicemia)
06/2022 - 01/2006
42Ovarian Neoplasms (Ovarian Cancer)
12/2022 - 01/2008
42Hemorrhage
06/2022 - 04/2004
39Mitochondrial Diseases (Mitochondrial Disease)
05/2022 - 03/2008
38Uterine Cervical Neoplasms (Cancer of the Cervix)
07/2022 - 09/2004
36Hyperglycemia
04/2022 - 06/2002

Drug/Important Bio-Agent (IBA)

559Proteins (Proteins, Gene)FDA Link
09/2022 - 03/2002
301Pharmaceutical PreparationsIBA
12/2022 - 08/2002
269Biomarkers (Surrogate Marker)IBA
10/2022 - 01/2006
177Biological ProductsIBA
10/2022 - 08/2003
167CytokinesIBA
11/2022 - 04/2002
163MicroRNAs (MicroRNA)IBA
12/2022 - 12/2005
152Messenger RNA (mRNA)IBA
11/2022 - 02/2003
127Glucose (Dextrose)FDA LinkGeneric
10/2022 - 06/2002
101Long Noncoding RNAIBA
08/2022 - 05/2012
94RNA (Ribonucleic Acid)IBA
11/2022 - 09/2003
89DNA (Deoxyribonucleic Acid)IBA
10/2022 - 01/2002
77EnzymesIBA
11/2022 - 10/2002
77Cisplatin (Platino)FDA LinkGeneric
07/2022 - 10/2008
77LipidsIBA
02/2022 - 12/2004
72Therapeutic UsesIBA
03/2022 - 04/2005
69Peptides (Polypeptides)IBA
04/2022 - 12/2003
65AntioxidantsIBA
03/2022 - 11/2004
64Small Interfering RNA (siRNA)IBA
11/2022 - 04/2008
62AntibodiesIBA
09/2022 - 12/2003
62Interleukin-6 (Interleukin 6)IBA
05/2022 - 04/2002
60Paclitaxel (Taxol)FDA LinkGeneric
07/2022 - 09/2008
60ErbB Receptors (EGF Receptor)IBA
06/2022 - 01/2002
59AntigensIBA
08/2022 - 06/2003
59Transcription Factors (Transcription Factor)IBA
07/2022 - 01/2004
58LigandsIBA
04/2022 - 08/2007
58Phosphotransferases (Kinase)IBA
02/2022 - 08/2006
58Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2022 - 07/2003
56CateninsIBA
09/2022 - 01/2012
56Insulin (Novolin)FDA Link
07/2022 - 06/2002
56Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2022 - 12/2004
53Reactive Oxygen Species (Oxygen Radicals)IBA
11/2022 - 06/2003
53Indicators and Reagents (Reagents)IBA
10/2022 - 02/2003
53VaccinesIBA
08/2022 - 12/2003
49Blood Glucose (Blood Sugar)IBA
07/2022 - 01/2011
44Anti-Bacterial Agents (Antibiotics)IBA
11/2022 - 10/2003
42CollagenIBA
07/2022 - 07/2004
40Antiviral Agents (Antivirals)IBA
02/2022 - 12/2003
39Oxygen (Dioxygen)IBA
04/2022 - 01/2007
38C-Reactive ProteinIBA
05/2022 - 01/2014
38InterferonsIBA
03/2022 - 02/2003
38ChromatinIBA
01/2022 - 07/2005
37Matrix Metalloproteinases (MMPs)IBA
11/2022 - 01/2002
37Circular RNAIBA
10/2022 - 03/2015
37Doxorubicin (Adriamycin)FDA LinkGeneric
08/2022 - 07/2005

Therapy/Procedure

693Therapeutics
12/2022 - 04/2002
246Drug Therapy (Chemotherapy)
11/2022 - 08/2002
100Immunotherapy
11/2022 - 07/2005
59Radiotherapy
07/2022 - 06/2003
41Chinese Traditional Medicine (Traditional Chinese Medicine)
06/2022 - 08/2008
40Transplantation
09/2022 - 07/2004
37Aftercare (After-Treatment)
01/2022 - 04/2004
35Stents
09/2022 - 06/2006
35Length of Stay
07/2022 - 10/2010